Compare Summit Therapeutics Inc (SMMT) vs Verisign, Inc. (VRSN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Summit Therapeutics Inc vs Verisign, Inc. — how do they compare? Summit Therapeutics Inc trades at $14.57 (market cap $10.48B), while Verisign, Inc. trades at $277.5 (market cap $25.26B). The key difference: Verisign, Inc. is far larger — about 2.4× Summit Therapeutics Inc's market cap, and Verisign, Inc. pays a 1.17% dividend while Summit Therapeutics Inc pays none. Which is the better fit depends on your goals.
| SMMT | VRSN | |
|---|---|---|
Market Cap | $10.48B | $25.26B |
Sector | Health | Technology |
52-Week High | $29.32 | $310.00 |
52-Week Low | $13.05 | $211.49 |
Enterprise Value | $9.90B | $26.50B |
Dividend Yield | — | 1.17% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Summit Therapeutics Inc
Summit Therapeutics Inc. is a biopharmaceutical company focused on the development and commercialization of new medicines for the treatment of infectious diseases and other unmet medical needs. The company's lead product candidate is an antibiotic for the treatment of Clostridioides difficile infection (CDI), a serious infection of the colon. Summit Therapeutics is committed to bringing innovative therapies to market to address global health challenges and improve patient outcomes.
Read more on SMMT →About Verisign, Inc.
Verisign is the sole authorized registry for several generic top-level domains, including the widely utilized .com and .net top-level domains. The company operates critical Internet infrastructure to support the domain name system, including operating two of the world's 13 root servers that are used to route Internet traffic. In 2018, the firm sold off its Security Services business, signalling a renewed focus on the core registry business.
Read more on VRSN →
